Public Healthcare Companies Meet Institutional Investors at the 5th Annual ROTH Healthcare Opportunities Conference
Executives From Biotech, Life Science Tools and Diagnostics, and MedTech Companies, Alongside Themed Panels and a Keynote on Drug Value, Pricing and Coverage
ROTH is a relationship-driven investment bank headquartered in Newport Beach, CA, focused on serving growth companies and their investors. Its full-service platform provides capital raising, equity research, macroeconomics, sales and trading, technical in
A Full Day of 25-Minute 1-on-1 and Small Group Meetings at The Metropolitan Club in New York City on September 29
As the first in-person ROTH conference of the fall season, I have no doubt ROTH will continue its pattern of delivering an exceptional experience for investors and companies.”
NEW YORK, NY, UNITED STATES, August 24, 2026 /EINPresswire.com/ -- B2i Digital, Inc. serves as Marketing Partner for the 5th Annual ROTH Healthcare Opportunities Conference, hosted by ROTH Capital Partners and held at The Metropolitan Club in New York City on Tuesday, September 29, 2026. B2i Digital supports the conference through digital marketing, its media network, social media, and company profiles.— David Shapiro, CEO of B2i Digital, Inc.
The 5th Annual ROTH Healthcare Opportunities Conference is a B2i Digital Featured Conference. ROTH built the program around time with management: 25-minute 1-on-1 and small group meetings that put institutional clients in front of C-level executives from public healthcare companies across biotech, life science tools and diagnostics, and medtech.
Meetings run from 8:00 AM to 4:30 PM. On the panel side, Frontiers in Neuroscience brings together Annovis Bio, CervoMed, Gain Therapeutics, MediciNova and ProMIS Neurosciences. Dr. Frank Lichtenberg, Professor Emeritus of Healthcare Management at Columbia University, speaks on The Economics of Drug Value: What It Means for Pricing and Coverage. The Biotech Reset panel covers regulatory uncertainty, capital constraints and the search for value, with Kendall Square Policy Strategies, PolyPid and Newron Pharmaceuticals. The Rise of MRD Monitoring in Solid Tumors, and Where it Goes Next features Biodesix, DeciBio and Memorial Sloan Kettering Cancer Center.
"As the first in-person ROTH conference of the fall season, I have no doubt ROTH will continue its pattern of delivering an exceptional experience for investors and companies. I look forward to catching up with everyone, meeting with some new companies and sitting in on the panels. To be honest, and I always am, I often skip the panels to work the room, but these topics may get me to sit still," said David Shapiro, Chief Executive Officer of B2i Digital.
For event details and profiles of participating companies: https://b2idigital.com/5th-annual-roth-healthcare-opportunities-conference
This is an invitation-only event and registration is subject to approval by ROTH. To request registration: https://www.meetmax.com/sched/event_139361/conference_home.html
Confirmed participants as of August 21, 2026 (subject to change):
908 Devices Inc. (Nasdaq: MASS)
Akari Therapeutics Plc (Nasdaq: AKTX)
Alpha Teknova, Inc. (Nasdaq: TKNO)
Annovis Bio, Inc. (NYSE: ANVS)
Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT)
BioAge Labs, Inc. (Nasdaq: BIOA)
Biodesix, Inc. (Nasdaq: BDSX)
CapsoVision, Inc. (Nasdaq: CV)
CervoMed Inc. (Nasdaq: CRVO)
Cingulate Therapeutics (Nasdaq: CING)
Clene Inc. (Nasdaq: CLNN)
Eos SENOLYTIX (private)
Equillium, Inc. (Nasdaq: EQ)
Gain Therapeutics, Inc. (Nasdaq: GANX)
MAXONA Pharmaceuticals, Inc. (private)
MediciNova, Inc. (Nasdaq: MNOV)
Medicus Pharma Ltd. (Nasdaq: MDCX)
Moleculin Biotech, Inc. (Nasdaq: MBRX)
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN)
Newron Pharmaceuticals S.p.A. (SIX: NWRN)
OS Therapies Incorporated (NYSE American: OSTX)
Ovid Therapeutics Inc. (Nasdaq: OVID)
Polaryx Therapeutics, Inc. (Nasdaq: PLYX)
PolyPid Ltd. (Nasdaq: PYPD)
ProMIS Neurosciences Inc. (Nasdaq: PMN)
Rapid Micro Biosystems, Inc. (Nasdaq: RPID)
Revelation Biosciences, Inc. (Nasdaq: REVB)
Serina Therapeutics, Inc. (NYSE American: SER)
Stereotaxis, Inc. (NYSE: STXS)
Trulieve Cannabis Corp. (NYSE: TRLV)
vTv Therapeutics, Inc. (Nasdaq: VTVT)
About ROTH Capital Partners
ROTH is a relationship-driven investment bank headquartered in Newport Beach, CA, focused on serving growth companies and their investors. Its full-service platform provides capital raising, equity research, macroeconomics, sales and trading, technical insights, derivatives strategies, M&A advisory, and corporate access. For more information, please visit https://www.roth.com.
About B2i Digital, Inc.
B2i Digital, Inc. partners with conferences, public companies, and capital markets advisors through its Featured Conference, Featured Company, and Featured Expert programs. Its media network spans 800+ news, broadcast, and trade outlets with a 330 million+ combined monthly audience, plus 1.7 million+ followers, 70,000 opt-in email subscribers, and a rolodex of 235,000+ capital markets contacts. That reach gets clients seen; its conferences put them in the room with investors. The Capital Markets Matchmaker℠ takes every story From Marketing to Meetings℠. B2i Digital is headquartered in New York City.
Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com.
B2i Digital Contact Information
David Shapiro
Chief Executive Officer
B2i Digital, Inc.
https://b2idigital.com
212.579.4844 Office
david@b2idigital.com
https://www.linkedin.com/in/davidshapironyc
Disclosure & Disclaimer
B2i Digital, Inc. is the Marketing Partner of the 5th Annual ROTH Healthcare Opportunities Conference. Content related to any specific company referenced in this release was provided by that company, approved by that company, or obtained from publicly available sources. B2i Digital, Inc. has not independently verified the accuracy or completeness of such information, and no representation or warranty, express or implied, is made as to its accuracy.
This content is provided for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security, nor should it be relied upon as the basis for any investment decision. B2i Digital, Inc. is not a registered broker-dealer, investment adviser, or financial adviser, and nothing herein should be construed as investment, legal, tax, or accounting advice. Readers should consult their own advisers and conduct their own due diligence before making any investment decision.
Media Contact:
David Shapiro
B2i Digital, Inc.
+1 212-579-4844
david@b2idigital.com
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
TikTok
X
Other
The 5th Annual ROTH Healthcare Opportunities Conference is a B2i Digital Featured Conference
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
